Purpose: We report here the results of an international field study of the practicality, reliability, and validity of the EORTC QLQ-C30, the current core questionnaire. The QLQ-C30 incorporates nine multi-item scales: five functional scales (physical, role, cognitive, emotional, and social); three symptom scales (fatigue, pain, and nausea and vomiting); and a global health and quality-of-life

EORTC QLQ-C30 Reference Values This manual presents reference data for the QLQ-C30 based upon data provided by EORTC Quality of Life Group Members and other users of the QLQ-C30 July 2008 Neil W Scott, Peter M Fayers, Neil K Aaronson, Andrew Bottomley, Alexander de Graeff, Mogens Groenvold, Chad

Totalt 162 patienter i crizotinibarmen och 151 patienter i kemoterapiarmen fyllde i frågeformulären EORTC QLQ-C30 och LC-13 vid studiestart och vid minst 1 QLQ-C30-skalan har totalt 30 artiklar inklusive. 5 funktionella A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and av; demografiska frågor, EORTC-QLQ-C30 och EORTC-QLQ-PR25 vilka båda är validerade livskvalitets instrument, samt ett antal frågor konstruerade för denna Dessa data baseras på förändrad hälsostatus mätt från studiestart till vecka 15, med verktygen EORTC QLQ-C30, samt EORTC QLQ-LC13. Patienterna i TRIUMPH-studien fick betydande förbättringar i livskvalitet mätt med EORTC. QLQ-C30 i jämförelse mot placebo (p≤0.01). Patienterna uppvisade 3 EORTC QLQ-C30 EORTC (European Organisation for Research and Treatment of Cancer) bildat 1962 EORTC QLQ-C30 validerat och publicerat 1993 EORTC QLQ-C30 European Organization for Research and Treatment of Cancer and Treatment of Cancer Quality of Life Questionnaire(EORTC QLQ-C30) []. weekly doses of bermekimab and be assessed for tumor-related wasting and other quality of life symptoms (using the EORTC QLQ-C30). emot antingen CisGem eller gemcitabin ensamt (Gem); 324 patienter samtyckte till att slutföra EORTC QLQ-C30 och EORTC QLQ-PAN26 QoL frågeformulär; av K KIRURGI · 2010 — livskvaliteten hos cancer patienter är EORTC-QLQ C30 och EORTC-CRC 38.

Qlq c30 eortc

Der QLQ-C30 ist ein validierter und aussagekräftiger Fragebogen, der zur Messung des Outcomes von onkologischen Patienten bereits in zahlreichen Studien verwendet wurde. 1,4-9 Darüber hinaus ist seine modulare Verknüpfung mit weiteren tumorspezifischen Fragebögen einzigartig und erlaubt eine tiefer gehende Beurteilung von Tumorpatienten. European Organization for Research and Treatment for Cancer Quality of Life Questionnaire EORTC QLQ-C30. De EORTC QLQ-C30 is een ziekte specifiek meetinstrument voor gebruik bij patiënten met of genezen van kanker dat een aantal aspecten van kwaliteit van leven beschrijft, waaronder: fysiek functioneren; rol functioneren; emotioneel functioneren ; cognitief functioneren; sociaal functioneren.

The EORTC Study Group on Quality of Life has developed a modular system for assessing the quality of life of cancer patients in clinical trials composed of two basic elements: (1) a core quality of life questionnaire, the EORTC QLQ-C30, covering general aspects of health-related quality of life, and (2) additional disease- or treatment-specific questionnaire modules.

JNCI Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Methods: Forty-eight gastric cancer patients, split up into equal sub- groups by age, sex, The European Organisation for Research and Treatment of Cancer (EORTC) core questionnaire, QLQ-C30, is a frequently used patient-reported outcome ( PRO) The EORTC.

EORTC QLQ-C15-PAL er en forkortet udgave af EORTC QLQ-C30, som er udviklet specielt til patienter, der modtager palliativ indsats. Målet var at fjerne de spørgsmål, der var unødvendige eller irrelevante for denne gruppe patienter for at gøre spørgeskemaet så kort og relevant som muligt.

EORTC QLQ-C15-PAL PDF - Addendum to the EORTC QLQ-C30 Scoring Manual: Scoring of the EORTC QLQ- CPAL.

The European Organization for Research and Treatment of Cancer core quality of life questionnaire, the EORTC QLQ-C30, is a cancer-specific quality The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Methods: Forty-eight gastric cancer patients, split up into equal sub- groups by age, sex, The European Organisation for Research and Treatment of Cancer (EORTC) core questionnaire, QLQ-C30, is a frequently used patient-reported outcome ( PRO) The EORTC. QLQ-C30 which this group developed has become the most widely used questionnaire in Europe for cancer patients, and is exten- sively used More- over, EORTC QLQ-C30 scales showed substantial correlation with the homologous SF-36 scales.
Dimension dack

5. EORTC Quality of Life Group website.

The purpose of this study was to develop a mapping relationship between the EORTC QLQ-C30 and EQ-5D-based utility values at the individual level for patients with a wide range of cancers.
Trådlöst wifi stationär dator

Formulär (EORTC QLQ-C30, FACT-G, SF-36) Intervjustudier - ringa in nya problem. Hur många mätpunkter ska man ha? Dvs hur ofta ska man mäta? Ju högre

Kvalitetsaspekter Test-retest-reliabilitet Bland 70 patienter ICC > 0,68 [2]. Aspekter att ta hänsyn till vid datainsamling och analys Tillstånd och användningsvillkor Se EORTC QLQ-C30. Användningsområde Hälsoläge och hälsoutveckling för jämförelse mellan grupper.

How to find how

The choice between the EORTC QLQ-C30, EORTC modules, the EORTC item library and the EORTC CAT measures or a combination of these measures facilitates the use of appropriate PRO instruments in a variety of PRO assessment settings.  The psychometric properties of EORTC QoL measures are stable across modes of administration (paper–pencil or computer-based), cultures and translations.

There are no "right" or "wrong" answers. The information that you provide will remain strictly confidential.